Researchers have developed a compound that could potentially treat the autoimmune disorder alopecia, which causes hair loss ...
Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, 575 West Stadium Avenue, West Lafayette, Indiana 47907, United States Department of Pharmaceutical Sciences, University ...
7 天
News-Medical.Net on MSNResearchers develop new compound to treat alopecia areataA research group, led by Dr. Pavel Majer from IOCB Prague, in collaboration with the laboratories of Barbara Slusher and ...
Zevra Therapeutics (NASDAQ:ZVRA – Get Free Report) will likely be announcing its earnings results before the market opens on ...
A research group, led by Dr. Pavel Majer from IOCB Prague, in collaboration with the laboratories of Barbara Slusher and ...
Medical Xpress on MSN14 天
A 'Trojan horse' approach may enable development of new antimalarial drugsHowever, one promising strategy for drug development is the use of prodrugs, which are used to improve a drug's ability to be ...
Based upon a successful engagement with the US Food and Drug Administration (FDA) at the End-of-Phase 2 meeting in January ...
Antimalarial drug resistance is a pressing issue in combating the spread of malaria worldwide. In a new study, researchers discovered a key process where malarial parasites take up a human blood cell ...
Researchers have developed a compound that could potentially treat the autoimmune disorder alopecia areata, which causes hair ...
The researchers tested their new itaconate-based prodrugs in mice and found that at least two of them were highly effective. The treatment was well-absorbed, reduced inflammation, and stimulated hair ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果